Krista Meyer

1.0k total citations
20 papers, 808 citations indexed

About

Krista Meyer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Krista Meyer has authored 20 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Krista Meyer's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Krista Meyer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Krista Meyer collaborates with scholars based in United States, Italy and Germany. Krista Meyer's co-authors include Dylan J. Taatjes, Matthew T. Knuesel, Carrie Bernecky, Aaron J. Donner, Joaquı́n M. Espinosa, Shih‐Chieh Lin, Autumn G. York, Heinrich Röder, Julia Grigorieva and Joanna Roder and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and The EMBO Journal.

In The Last Decade

Krista Meyer

18 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krista Meyer United States 10 582 250 86 76 68 20 808
Shih-Ya Wang United States 8 666 1.1× 203 0.8× 47 0.5× 136 1.8× 26 0.4× 9 751
Jessica C. Pole United Kingdom 18 620 1.1× 199 0.8× 100 1.2× 305 4.0× 37 0.5× 22 887
Gianluca Sigismondo Germany 14 612 1.1× 161 0.6× 65 0.8× 61 0.8× 89 1.3× 21 876
Alexandra C. Kölbl Germany 12 339 0.6× 116 0.5× 27 0.3× 84 1.1× 75 1.1× 22 463
Zhanwen Du United States 13 712 1.2× 130 0.5× 36 0.4× 258 3.4× 87 1.3× 17 867
Ou Li United States 10 423 0.7× 232 0.9× 31 0.4× 107 1.4× 121 1.8× 15 662
Keelan Z. Guiley United States 11 604 1.0× 273 1.1× 100 1.2× 123 1.6× 39 0.6× 15 804
R. Gätje Germany 16 507 0.9× 291 1.2× 67 0.8× 206 2.7× 85 1.3× 24 865
Christopher G. Danes United States 8 508 0.9× 306 1.2× 61 0.7× 129 1.7× 36 0.5× 12 690
Eun‐Kyoung Breuer United States 13 309 0.5× 181 0.7× 65 0.8× 152 2.0× 22 0.3× 17 475

Countries citing papers authored by Krista Meyer

Since Specialization
Citations

This map shows the geographic impact of Krista Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krista Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krista Meyer more than expected).

Fields of papers citing papers by Krista Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krista Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krista Meyer. The network helps show where Krista Meyer may publish in the future.

Co-authorship network of co-authors of Krista Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Krista Meyer. A scholar is included among the top collaborators of Krista Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krista Meyer. Krista Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahalingam, Devalingam, Leonidas Chelis, Sunyoung S. Lee, et al.. (2021). Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test. Cancers. 13(13). 3109–3109. 5 indexed citations
2.
Roder, Joanna, Carlos Oliveira, Krista Meyer, et al.. (2020). A proposal for score assignment to characterize biological processes from mass spectral analysis of serum. PubMed. 18. 13–26. 1 indexed citations
3.
Tsypin, Maxim, et al.. (2019). Extending the information content of the MALDI analysis of biological fluids via multi-million shot analysis. PLoS ONE. 14(12). e0226012–e0226012. 15 indexed citations
4.
Ascierto, Paolo A., Mariaelena Capone, Antonio Maria Grimaldi, et al.. (2019). Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations. Journal for ImmunoTherapy of Cancer. 7(1). 91–91. 26 indexed citations
5.
Weber, Jeffrey S., Mario Sznol, Ryan J. Sullivan, et al.. (2017). A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma. Cancer Immunology Research. 6(1). 79–86. 53 indexed citations
6.
Grossi, Francesco, Erika Rijavec, Federica Biello, et al.. (2017). P3.02c-074 Evaluation of a Pretreatment Serum Tests for Nivolumab Benefit in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S1322–S1322. 7 indexed citations
7.
Grossi, Francesco, Carlo Genova, Erika Rijavec, et al.. (2017). Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy. Lung Cancer. 117. 64–69. 12 indexed citations
8.
Oliveira, Carlos, et al.. (2017). Abstract 210: Development of scores reflective of biological processes underlying human disease states from mass spectrometry of serum. Cancer Research. 77(13_Supplement). 210–210. 1 indexed citations
9.
Grossi, Francesco, Erika Rijavec, Carlo Genova, et al.. (2016). Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy. British Journal of Cancer. 116(1). 36–43. 16 indexed citations
10.
Weber, Jeffrey S., et al.. (2016). Abstract 4891: A mass spectrometry-based serum test to predict outcome of treatment with nivolumab: Analysis of samples taken during therapy. Cancer Research. 76(14_Supplement). 4891–4891. 2 indexed citations
11.
Weber, Jeffrey S., Alberto J. Martinez, Heinrich Röder, et al.. (2015). Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P103–P103. 5 indexed citations
12.
Cardin, Dana B., Laura W. Goff, Yu Shyr, et al.. (2014). Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer. Cancer Medicine. 3(3). 572–579. 28 indexed citations
13.
Röder, Heinrich, Sabine Kasimir‐Bauer, Rainer Kimmig, et al.. (2013). Serum mass spectrometry analysis in primary ovarian cancer (OC) treated with surgery and adjuvant chemotherapy (CT).. Journal of Clinical Oncology. 31(15_suppl). 5575–5575. 1 indexed citations
14.
Cardin, Dana B., Laura W. Goff, Emily Chan, et al.. (2013). Phase II trial of sorafenib (S) and erlotinib (E) in unresectable pancreas cancer (UPC): Final results and correlative findings.. Journal of Clinical Oncology. 31(4_suppl). 191–191. 2 indexed citations
15.
16.
Meyer, Krista, et al.. (2010). p53 activates transcription by directing structural shifts in Mediator. Nature Structural & Molecular Biology. 17(6). 753–760. 108 indexed citations
17.
Knuesel, Matthew T., Krista Meyer, Carrie Bernecky, & Dylan J. Taatjes. (2009). The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes & Development. 23(4). 439–451. 262 indexed citations
18.
Meyer, Krista, et al.. (2008). Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3. The EMBO Journal. 27(10). 1447–1457. 84 indexed citations
19.
Delmonico, F L, K. O’Connor, Richard Pietroski, et al.. (2008). FACTORS PREDICTIVE OF THE DISCARD OF ECD KIDNEYS DO NOT PREDICT OUTCOME. Transplantation. 86(2S). 23–23. 3 indexed citations
20.
Knuesel, Matthew T., Krista Meyer, Aaron J. Donner, Joaquı́n M. Espinosa, & Dylan J. Taatjes. (2008). The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator. Molecular and Cellular Biology. 29(3). 650–661. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih-Ya Wang Breakdown of academic impact, for papers by Jessica C. Pole Breakdown of academic impact, for papers by Gianluca Sigismondo Breakdown of academic impact, for papers by Alexandra C. Kölbl Breakdown of academic impact, for papers by Zhanwen Du Breakdown of academic impact, for papers by Ou Li Breakdown of academic impact, for papers by Keelan Z. Guiley Breakdown of academic impact, for papers by R. Gätje Breakdown of academic impact, for papers by Christopher G. Danes Breakdown of academic impact, for papers by Eun‐Kyoung Breuer
Rankless by CCL
2026